Figure 9: Molecular Structures of Enumerated Ligands Against Neuraminidase of Influenza a (A1–A10) and B (B1–B10) Are Categorized According to Their Scaffold Types and Compared to FDA-approved Drugs (e.g., Zanamivir, Oseltamivir and Peramivir) as Well as the Long-Acting Laninamivir.
doi 10.7717/peerj.1958/fig-9
